Additionally, patients should report any concerning symptoms during routine follow-up appointments
PubMed Central, Weghuber, Daniel, et al
3 Note that this consensus algorithm is a guide and that the clinical management of T2DM should always incorporate the patients unique goals, comorbidities, individual response to therapy, and other factors that may introduce unwanted drug interactions or contraindications to a particular therapy or therapies
We also inferred that the regulation of insulin levels by T3 treatment is also likely attributed to the chronic but not acute effect of T3
JCI Insight 5 , e140532 (2020)
It has also been claimed to help with weight management however, theres currently not enough proof of this effect for products to use it in Europe as a health claim